about
Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndromeAnalysis of circulating tumor DNA to monitor metastatic breast cancerNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAOrdering of mutations in preinvasive disease stages of esophageal carcinogenesis.Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.Targeted therapy for BRAFV600E malignant astrocytoma.Three different brain tumours evolving from a common originMutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complexMAPK pathway activation and the origins of pediatric low-grade astrocytomas.Replication timing profile reflects the distinct functional and genomic features of the MHC class II region.Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology.Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism
P50
Q24322437-EC7A42DF-0D30-470D-A9B5-1D0CF37F5A95Q29614797-1546F9A4-4D45-4560-8C34-45B922B22BE8Q29620083-CE9D575D-3BEF-4B6C-9B1E-C02D02B79E75Q33975855-4D3722FD-3868-4A7B-B460-F0F706BAA7B6Q34278191-37876C23-629A-46E8-BB59-49467675C226Q36800148-9409ABF4-81AB-4CB5-86AC-6BC84010B82CQ36809583-127F3B50-14CB-4B41-BC61-3DAE2F0D0635Q36852678-49974A25-1DEA-46B7-8443-1C353D3E97A4Q36961247-5AFE493E-DC45-4532-B2BD-B2342F839772Q37638497-EEC8837D-246E-428C-B35A-BBBAEB0956ADQ40067345-A85A3690-FA1D-4A92-B9B1-4827DC16167CQ40498502-2DCC63D2-3C75-4764-92B4-58CDF0022FC2Q41817199-BC27F13C-941D-4F30-A60A-F109BD24BD45Q43806776-0E922C46-B9AE-4176-AE32-C7CB9E238ABFQ47931157-5C2C0C0F-6231-4683-BBA5-94DF62D49E42Q47992753-DDDF6349-D7C6-4AA9-933D-553F5F647607Q53078885-BBB02CB4-52E1-45EC-B985-1DC36C635FF7Q81923030-1867BBA2-9402-4EA2-899F-B99C64115337
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tim Forshew
@ast
Tim Forshew
@en
Tim Forshew
@es
Tim Forshew
@nl
Tim Forshew
@sl
type
label
Tim Forshew
@ast
Tim Forshew
@en
Tim Forshew
@es
Tim Forshew
@nl
Tim Forshew
@sl
prefLabel
Tim Forshew
@ast
Tim Forshew
@en
Tim Forshew
@es
Tim Forshew
@nl
Tim Forshew
@sl
P106
P1153
6506634124
P21
P31
P496
0000-0003-2093-7020